Hepatology
Conditions
Interventions
Gold Standard:clinical outcome
Index test:Serum 
anti-beta 
adrenergic 
Sponsors
Beijing You'an Hospital Affiliated to Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Patients aged 18-65 years; 2. All patients were diagnosed as cirrhosis by clinical, laboratory and imaging examination; 3. Patients with cirrhosis and cardiomyopathy.
Exclusion criteria
Exclusion criteria: 1. Patients with severe anemia (Hgb < 60g / L); 2. Patients with fever or SIRS; 3. Patients with alcoholic liver disease; 4. Patients with primary and secondary cardiovascular diseases, such as hypertension, coronary heart disease, rheumatic heart disease, congenital heart disease, etc; 5. Patients with other acute and chronic diseases that may affect cardiac function, such as acute and chronic respiratory diseases, thyroid diseases, etc; 6. Patients with malignant tumor; 7. Patients who took drugs that affect cardiac function in the past week (beta blockers, calcium channel blockers, angiotensin-converting enzyme inhibitors, etc.).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| serum anti-beta 1 adrenergic receptor antibody;SEN, SPE, ACC, AUC of ROC; | — |
Countries
China
Contacts
Public ContactLixia Ma
Beijing You'an Hospital Affiliated to Capital Medical University
Outcome results
None listed